J
JSPR
Jasper Therapeutics Inc
0.4927
+0.0114+2.37%After Hours: 0.4901 -0.0026 -0.53%19:49 06/05 EDT
OPEN/PREV CLOSE0.4678/0.4680
TODAY RANGE0.4200-0.5000
VOL407.27K
MARKET CAP13.05M
52 WEEK RANGE0.4200-7.19
AVG VOL (3M)503.07K
% TURNOVER1.45%
TURNOVER--
P/E (TTM)-0.1444
% RANGE14.96%
EPS(TTM)-3.2262
P/E(FORWARD)-0.5482
P/B3.839
BVPS0.1214
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.89M
SHARES OUTSTANDING28.00M
NEXT EARNINGS08/11-08/17
FREE FLOAT27.66M
LOT SIZE1
EX-DATE01/04/2024
News
Press Releases
Financial Reports
Profile
TipRanks·4h ago
Jasper Therapeutics Receives Nasdaq Minimum Bid Price Notice
Reuters·06/01 17:40
BUZZ-U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic
Reuters·06/01 15:43
BUZZ-U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant
Reuters·06/01 13:13
BUZZ-U.S. STOCKS ON THE MOVE -Revolution Medicines, FedEx, Cummins
TipRanks·06/01 12:39
Jasper Therapeutics Launches Strategic Alternatives Review Amid Uncertainty
Reuters·06/01 12:28
BUZZ-Jasper Therapeutics rises as company explores sale, strategic options
TipRanks·06/01 12:26
Jasper Therapeutics initiates review of strategic alternatives
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.